Turkish Products Distribution

As an expert group in the field, we propose well-documented, high-quality (EU-standard) Turkish pharmaceuticals  at competitive prices for emerging markets. 

The Turkish pharmaceutical industry has a long-standing tradition of high-quality production, with EU-approved manufacturing facilities that fully compatible to the latest European standards in technology, capacity, documentation, and quality assurance. Turkey has been a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) since 2018—alongside the U.S., Germany, Australia, Switzerland, Japan, and Canada—and a regulatory member of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) since 2020. These global memberships ensure that pharmaceutical products manufactured and approved in Turkey meet internationally recognized quality and regulatory standards. 

With 81 production facilities, approximately 500 pharmaceutical companies, and over 35,000 employees, the Turkish pharmaceutical industry manufactures more than 11,000 products. In recent years, the industry has demonstrated strong export growth, reaching $1.92 billion in 2022 and $2.23 billion in 2023, with a significant portion of exports directed to Europe, Asia, and the Middle East. 

We are actively seeking reliable partners to establish long-term collaborations. Our goal is to introduce, register, and commercialize high-quality Turkish pharmaceutical products, ensuring accessibility to affordable and well-documented medicines. 

Get in touch with us directly if you have any questions or require further information.